The relationship between PD‐L1 and T cell infiltration in glioma, as well as the therapeutic effects of anti‐PD‐1/PD‐L1 antibodies, remain largely elusive, which may reflect the specificity of the cellular and structural microenvironment in the brain.30 This evidence concerns the gene CD274 and central nervous system cancer.